Overview
The autoclave is a device that is primarily used for disinfection and sterilizing. The autoclave uses a physical technique to control temperature and pressure for sterilizing procedures in a shorter amount of time. In healthcare, autoclaves are used for sterilizing and pre-disposal of medical equipment and materials.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2124
Drivers
One of the key reasons driving market expansion is the rising incidence of infections connected to healthcare. The growing incidence of Hospital-Acquired Infections (HIA) as well as the occurrence of pathogens, bacterial, fungal, and viral illnesses globally are factors driving the global autoclave market. As per the Centers for Disease Control and Prevention (CDC), about 99,000 individuals die each year from HIA infections across the world. Moreover, as per the World Health Organization (WHO), these infections affect around 15% of all hospitalized patients each year. The increase in HIA infections during hospitalization is owing to patients’ exposure to pathogens from a variety of sources, including the environment, healthcare personnel, and other sick patients. Since autoclaves are used to sterilize surgical equipment, laboratory tools, and pharmaceutical products, they serve an essential role in preventing HIA infections in hospitals. This, in turn, aids in the prevention of bacteria development, which incidentally aids in the reduction of sickness caused by infection transferred through medical devices. As a result, this aspect is projected to propel the global autoclave market forward over the forecast period (2018 – 2026).
Restraints
One of the factors limiting market expansion is the high cost of autoclaves. As a result, the price of an autoclave varies depending on the functions it provides, and this issue is estimated to limit the global autoclave market expansion.
Regional Analysis
In 2017, the Asia Pacific region had the biggest market share for autoclaves, and it is projected to continue to do so during the forecast period (2018 – 2026). One of the key reasons driving market expansion in this area is the rise in the number of patients with severe Hospital Acquired Infection (HIA). The International Nosocomial Infection Control Consortium (INICC) compared device-associated infection rates in 40 Indian hospitals to those in a number of other countries. As a result, in order to reduce the number of cases of HIA infection, the demand for autoclaves in these areas has accidentally increased.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2124
An additional factor fueling the market’s growth is the implementation of government state policies aimed at reducing and avoiding the prevalence of health-related infections. The state policy will be based on a WHO-developed model that will be deployed in public hospitals. In 2004, the World Health Organization (WHO) issued a national patient safety strategy to address concerns such as hand cleanliness, antibiotic resistance, and safe injections. The creation of the India Patient Safety Organization (IPSO) would be the first organization in India to take on the task of teaching healthcare professionals about patient safety, which will help to improve patient safety. As a result, all of these factors are projected to fuel market expansion in this region.
Competitive landscape
Major companies contributing in the global autoclave market are Astell Scientific, BMM Weston Ltd., Panasonic Biomedical Sales Europe B.V., Belimed, Shinva Medical Instrument Co., LTD., Tuttnauer, MELAG Medizintechnik oHG, Consolidated Sterilizer Systems, Accumax India, Getinge AB, Life Steriware, SAKURA SEIKI Co., Ltd., Priorclave Ltd., LTE Scientific Ltd, and STERIS plc.
To obtain a competitive advantage in the global autoclave market, the major companies followed a product development approach. Astell Scientific, the major producer of autoclaves, steam generators, and wastewater decontamination systems, announced the debut of a new and enhanced autoclave line in September 2017. The new circular cylinder autoclaves come in a variety of sizes and configurations, including tabletop, small, and free-standing models, as well as top and front loading choices.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837